INTRODUCTION
In all organisms, drug biotransformation enzymes serve as an efficient defence against the potential negative action of xenobiotics, with the activities of biotransformation enzymes determining both desired and undesired effects of drugs. Although several types of biotransformation enzymes including oxidases, reductases, hydrolases, transferases and transporters have been described in various helminth species, the metabolism of anthelmintics in helminths has been relatively little investigated (Cvilink et al. Reference Cvilink, Lamka and Skálová2009a ).
Biotransformation of benzimidazole anthelminthics albendazole (ABZ) and triclabendazole (TCBZ) has been studied in several helminths, including Haemonchus contortus, with significant inter-species differences being observed (Solana et al. Reference Solana, Rodriguez and Lanusse2001; Mottier et al. Reference Mottier, Virkel, Solana, Alvarez, Salles and Lanusse2004; Robinson et al. Reference Robinson, Lawson, Trudgett, Hoey and Fairweather2004; Alvarez et al. Reference Alvarez, Solana, Mottier, Virkel, Fairweather and Lanusse2005; Cvilink et al. Reference Cvilink, Lamka and Skálová2009a , Reference Cvilink, Lamka and Skálová b ). In H. contortus, the conjugation of ABZ with glucose has been revealed (Cvilink et al. Reference Cvilink, Skálová, Szotáková, Lamka, Kostiainen and Ketola2008b ). Alvinerie and his coworkers (2001) have reported the formation of one metabolite of the anti-parasitic drug moxidectin in H. contortus homogenate incubations. On the other hand, H. contortus was not able to metabolize closantel, neither in vitro nor ex vivo (Rothwell and Sangster, Reference Rothwell and Sangster1997). When the biotransformation of flubendazole (FLU) was studied in H. contortus, the formation of FLU with a reduced carbonyl group (FLU-R) along with glucosides of FLU and FLU-R were found (Cvilink et al. Reference Cvilink, Kubíček, Nobilis, Křížová, Szotáková, Lamka, Várady, Kuběnová, Novotná, Gavelová and Skálová2008a , Reference Cvilink, Skálová, Szotáková, Lamka, Kostiainen and Ketola b ).
The importance of investigating biotransformation enzymes in the helminth increased when several studies showed a direct association between biotransformation enzymes and drug resistance (Brennan et al. Reference Brennan, Fairweather, Trudgett, Hoey, McCoy, McConville, Meaney, Robinson, McFerran, Ryan, Lanusse, Mottier, Alvarez, Solana, Virkel and Brophy2007). A significantly faster oxidation of TCBZ and a greater conversion of TCBZ-sulphoxide to TCBZ-sulphone have been found in resistant Fasciola hepatica as compared to susceptible individuals (Robinson et al. Reference Robinson, Lawson, Trudgett, Hoey and Fairweather2004; Alvarez et al. Reference Alvarez, Solana, Mottier, Virkel, Fairweather and Lanusse2005). The metabolic inhibitors enhanced the drug susceptibility of a triclabendazole-resistant isolate of F. hepatica (Devine et al. Reference Devine, Brennan, Lanusse, Alvarez, Trudgett, Hoey and Fairweather2010a , Reference Devine, Brennan, Lanusse, Alvarez, Trudgett, Hoey and Fairweather b ).
Although drug-resistance in H. contortus is very common and several strains with different tolerance toward anthelmintics have been isolated, no information about differences in the biotransformation of anthelmintics among H. contortus strains has been made available. Moreover, while the results mentioned above clearly prove the importance of oxidation biotransformation enzymes in drug resistance, the contribution of other biotransformation enzymes to helminth resistance remains unknown. Therefore, the present study was designed to compare the biotransformation of FLU in H. contortus strains susceptible and resistant to anthelmintics. The benzimidazole drug FLU was chosen, as its biotransformation consists of the reduction of a carbonyl group and the formation of glucose conjugates in helminths (Cvilink et al. Reference Cvilink, Kubíček, Nobilis, Křížová, Szotáková, Lamka, Várady, Kuběnová, Novotná, Gavelová and Skálová2008a ,Reference Cvilink, Skálová, Szotáková, Lamka, Kostiainen and Ketola b ). Although FLU has not been commonly used in the treatment of haemonchosis, FLU efficacy against H. contortus has been described (Bártíková et al. Reference Bártíková, Křížová, Lamka, Kubíček, Skálová and Szotáková2010).
For this purpose 4 strains of H. contortus were used: the ISE strain (fully susceptible to anthelmintics), the ISE-S strain (resistant to ivermectin), the BR strain (resistant to benzimidazoles) and the WR strain (multi-resistant) in vitro as well as ex vivo. Assays of the in vitro activities of selected biotransformation enzymes have also been included in the study.
MATERIALS AND METHODS
Chemicals
FLU was purchased from Toronto Research Chemicals Inc. (North York, ON, Canada). FLU-R was obtained from Janssen Pharmaceutica. Liquid sterile-filtered RPMI medium (Roswell Park Memorial Institute medium) and all other chemicals (HPLC or analytical grade) were obtained from Sigma-Aldrich (Prague, Czech Republic).
Collection of parasite material
One susceptible isolate of Haemonchus contortus –ISE and 3 resistant strains – White river (WR), ISE-S and benzimidazole-resistant strain (BR) have been used in this study. The H. contortus ISE strain is an anthelminthic-susceptible inbred type of the SE strain (Roos et al. Reference Roos, Otsen, Hoekstra, Veenstra and Lenstra2004), which had been isolated from the field before benzimidazole anthelmintics were introduced to the market. BR strain is an inbred benzimidazole-resistant strain developed from the RE4 and SE population (Roos et al. Reference Roos, Otsen, Hoekstra, Veenstra and Lenstra2004). The South African, multi-resistant WR isolate has been isolated from the field, and it has demonstrated resistance to ivermectin (30% efficacy at 0·2 mg/kg) as well as the benzimidazoles, rafoxanide and closantel (Van Wyk and Malan, Reference Van Wyk and Malan1988). The ISE-S isolate has been laboratory selected for ivermectin resistance in the Moredun Research Institute, Edinburgh, UK. Third-stage larvae (L3) of H. contortus strains were the kind gift of Dr Frank Jackson, Moredun Research Institute, Edinburgh, UK.
Twelve parasite-free lambs (3–4 months old) were orally infected with L3 larvae of H. contortus. Each animal obtained a suspension with 5000 L3 larvae. Seven weeks after infection the animals were stunned and immediately exsanguinated in agreement with Czech slaughtering rules for farm animals. Adult nematodes were removed from sheep abomasum using the agar method described by Van Wyk et al. (Reference Van Wyk, Gerber and Groeneveld1980).
Preparation of subcellular fractions
The subcellular fractions from homogenates of H. contortus adults were prepared as described previously (Cvilink et al. Reference Cvilink, Kubíček, Nobilis, Křížová, Szotáková, Lamka, Várady, Kuběnová, Novotná, Gavelová and Skálová2008a ). Protein concentrations were assayed using the bicinchoninic acid method according to the Sigma protocol.
Biotransformation of FLU ex vivo
Living nematodes were cultivated as described by Kotze and McClure (Reference Kotze and McClure2001) with mild modification according to Cvilink et al. (Reference Cvilink, Skálová, Szotáková, Lamka, Kostiainen and Ketola2008b ). At the beginning of incubation, 2·5 ml of medium was removed from each flask with nematodes and the same volume of fresh medium with anthelmintics was added. FLU was pre-dissolved in DMSO; the concentration of DMSO in medium was 0·1%. Nematodes were incubated in medium with anthelmintic (10 μM) for 24 h. In the first type of blank samples, medium with FLU but without nematodes was incubated. The second type contained drug-free medium with 0·1% DMSO and the parasite material. After incubation, medium was placed into the plastic tubes. The nematodes were repeatedly washed with phosphate-buffered saline and transferred into the plastic tubes. Samples were frozen and stored at −80°C.
All samples were extracted by liquid/liquid (LL) extraction. Mebendazol (MBZ) at a concentration of 50 μM was used as an internal standard (IS). For LL extraction of medium, 10 μl of IS were added to 900 μl of medium and then the medium was divided into 3 equal parts. To each part, 30 μl of ammonium solution (concentrated, 25%, v/v) and 700 μl of ethyl acetate were added. Then samples were shaken (10 min, vortex) and centrifuged (1 min, 3000 g ). Supernatants from all 3 parts were put together and evaporated to dryness using an Eppendorf concentrator at 30°C. Frozen nematodes were quickly homogenized using Sonopuls in 300 μl of redistilled water with 10 μl of IS. Then 30 μl of ammonium solution (concentrated, 25%, v/v) and 700 μl of ethyl acetate were added and samples were shaken (10 min, vortex) and centrifuged (1 min, 3000 g ). Supernatant was collected in the test tube and extraction was repeated. Supernatants from both extractions were combined and evaporated to dryness as described above. Dried extracts were stored (−20°C) until LC-MS analyses.
Liquid chromatography/mass spectrometry
For LC-MS measurements a slightly modified method as published by Cvilink et al. (Reference Cvilink, Szotáková, Vokřál, Bártíková, Lamka and Skálová2009c ) was used. The liquid chromatography system consisted of a Surveyor MS pump and a Surveyor autosampler (both ThermoFinnigan, San Jose, CA, USA). A SymmetryShield RP 18 (2·1×100 mm, 3·5 μm; Waters, Milford, USA) column was used. The mobile phase consisted of solvent A (0·1% (v/v) aqueous formic acid) and solvent B (0·1% (v/v) formic acid in acetonitrile). The flow rate of the mobile phase was 120μl min−1. The gradient used in this method is described in detail in Table 1.
The column compartment temperature was set to 40°C. The MS/MS experiments were performed with an LCQ Advantage ion trap mass spectrometer (ThermoFinnigan, San Jose, CA, USA) equipped with an electrospray ionization (ESI) source. Before the experiments, the mass spectrometer was tuned for the best optimization using a direct infusion of FLU standard. All measurements were performed in positive ion mode. The analytes FLU-R, FLU-R-gluc, FLU-gluc1, FLU-gluc2, and MBZ were detected by monitoring the SRM transitions. For further information about analytes see Table 2.
Formation of FLU-R in vitro and high performance liquid chromatography
The reaction mixture (total volume of 0·3 ml) contained 50 μl of cytosol-like fractions containing 0·4–0·6 mg of proteins, FLU (10 μM) pre-dissolved in dimethyl sulfoxide (the concentration of DMSO in reaction mixture was 1%), NADPH (1 mM) and 0·1 M Na-phosphate buffer, pH 7·4. The blank samples contained 50 μl of 0·1 M sodium phosphate buffer, pH 7·4, instead of cytosols or 1% DMSO instead of FLU. In the inhibition study, the following inhibitors were tested: menadione (MEN), pyridinecarboxaldehyde (PCA), naloxone (NAL), metyrapone (MET). The concentration of inhibitors was 100 μM in the incubation mixture.
All incubations were carried out at 37°C for 30 min under aerobic conditions. The product formation was linear up to 60 min. At the end of the incubation, 30μl of ammonium solution (concentrated) and 700 μl of cooled ethyl acetate were added, shaken (3 min, vortex) and centrifuged (10 min, 10 000 g ). Supernatants were evaporated and stored at −20°C until HPLC analyses.
Chromatographic analyses were performed using an Agilent Technologies 1200 SL liquid chromatograph that consisted of a vacuum microdegasser, a 1200 SL binary pump, a 1200 SL plus autosampler, a TCC Infinity 1290 column thermostat and a 1200 SL diode-array detector. The chromatographic system was controlled by an Agilent ChemStation, version B.04.02 extended by a spectral module. The core-shell Ascentis® Express C18 (100×3·0 mm; 2·7 μm) column and the Supelguard Ascentis® C18 (20×4·0 mm; 3 μm) pre-column were utilized. An isocratic mobile phase was a mixture of KH2PO4 buffer (0·025 mol/l, pH 3) and acetonitrile (72 : 28) delivered at a flow rate of 0·8 ml/min. Detection conditions were found and described earlier (Kubíček et al. Reference Kubíček, Soukupová, Nobilis, Křížová, Szotáková and Skálová2008). This analytical method was validated and a very low limit of FLU-R quantification (0·63 nmol/l) was found. Fifty μl of each sample was injected.
Formation of glucose conjugates in vitro
Microsome-like fractions from homogenates of H. contortus adults were pre-incubated with detergent slovasol (dissolved in redistilled water) for 20 min, at 4°C. The amount of detergent was determined according to protein concentration to keep a ratio of 1:2 (detergent : protein). Pre-incubated fractions (200 μl containing 2·5–3·0 mg of proteins) were added to reaction mixtures (total volume 300 μl) containing 10 μM substrate FLU or FLU-R (pre-dissolved in DMSO), 100 μM UDP-glucose (dissolved in water) and 0·01M Tris/HCl buffer, pH 7·4. The blank samples contained 200 μl of 0·1 M sodium phosphate buffer, pH 7·4, instead of subcellular fractions. Incubations at 37°C lasted 60 min. At the end of the incubation, 30 μl of ammonium solution (concentrated) and 700 μl of cooled ethyl acetate were added, shaken (3 min, vortex) and centrifuged (10 min, 10 000 g ). Supernatants were evaporated and stored at −20°C until LC-MS analyses as described above.
Enzyme assays
Enzyme assays were performed in the subcellular fractions of the H. contortus homogenate. Each enzyme assay was performed in triplicate.
The activities of the reductases of the carbonyl group were tested using the following substrates: metyrapone, pyridinecarboxaldehyde, naloxone (all dissolved in redistilled water) and menadione (dissolved in ethanol). The amount of organic solvents in the final reaction mixtures did not exceed 1% (v/v). The concentrations of substrates, NADPH and potassium phosphate buffer, pH 6·8 were 1 mM, 0·3 mM and 0·1 M, respectively. The cytosolic fraction (50 μl, containing 0·26–0·32 mg of proteins) was added into the reaction mixture (total volume 1 ml). Spectrophotometric determination (detection wavelength 340 nm, 37°C) of NADPH consumption in the reaction mixture served for the assessment of reductase activities (Ohara et al. Reference Ohara, Miyabe, Deyashiki, Matsuura and Hara1995; Maté et al. Reference Maté, Virkel, Lifschnitz, Ballent and Lanusse2008).
UDP-glucosyltransferase (UGlcT) activity was assayed in microsome-like fractions using p-nitrophenol as a substrate according to the method of Mizuma et al. (Reference Mizuma, Machida, Hayashi and Awazu1982). The concentration of p-nitrophenol (pre-dissolved in redistilled water) was 3·3 μM. Absorbance was measured using the microplate reader Tecan Infinity M 200 (detection wavelength 415 nm).
Statistical analysis
The reported data are expressed as the mean±S.D. of 3–6 replicates. Statistical comparisons were carried out using a non-parametric permutation (randomization) test (Microsoft Office Excel 2010). A probability of P<0.05 was considered statistically significant.
RESULTS
Biotransformation of FLU ex vivo
Living nematodes of 4 H. contortus strains were incubated in a medium with FLU. After 24 h, the medium and nematodes were collected separately and frozen. In the medium and homogenates of nematodes, FLU metabolites were identified and quantified using LC-MS. Four different FLU metabolites were detected: FLU with a reduced carbonyl group (FLU-R), a glucose conjugate of FLU-R and 2 glucose conjugates of FLU (Fig. 1).
FLU-R and FLU-R-glucoside (FLU-R-gluc) represented the major metabolites, while 2 FLU-glucosides (FLU-gluc1 and FLU-gluc2) were the minor ones. The amounts of metabolites were semi-quantified using a ratio of peak areas for the metabolites and the area of the internal standard peak, related to the wet mass of nematodes in the incubation. The formation of FLU-R metabolites during ex vivo incubations in the 4 H. contortus strains is compared in Fig. 2. The amount of FLU-R found in the medium and the homogenates was significantly higher in all the resistant strains as compared to the susceptible ISE strain.
The formation of FLU and FLU-R glucose conjugates is shown in Fig. 2. In homogenates, all 3 glucosides (FLU-R-gluc, FLU-gluc1 and FLU-gluc2) were semi-quantified; the amount of FLU-gluc2 in the medium was under the limit of quantification. In all resistant strains (both medium and homogenate), a significantly higher formation of glucose conjugates was observed in comparison to the susceptible ISE strain. The amount of FLU-R-gluc and both FLU-glucosides was increased, especially in the multi-resistant WR strain. This strain formed approximately 5 times more conjugates than the susceptible ISE strain.
Biotransformation of FLU in vitro
The ability of H. contortus to form FLU with a reduced carbonyl group (FLU-R) was tested in cytosol-like fractions prepared from homogenates of 4 H. contortus strains, as FLU reduction is mainly catalysed by cytosolic reductases (Cvilink et al. Reference Cvilink, Kubíček, Nobilis, Křížová, Szotáková, Lamka, Várady, Kuběnová, Novotná, Gavelová and Skálová2008a ). The amounts of FLU-R were quantified using HPLC with spectrofluorimetric detection. In vitro, specific activities of FLU reductases were 0·12–0·16 pmol/min/mg of proteins. No significant differences in FLU reductase activities in individual strains were observed.
With the goal of revealing the potential competitive inhibitors and to estimate which enzymes participate in FLU reduction, the effect of selected model substrates of carbonyl-reducing enzymes on FLU reduction was tested. The obtained results (Fig. 3) showed menadione as an effective inhibitor and pyridinecarboxaldehyde as a mild inhibitor of FLU reduction in H. contortus cytosol-like fraction. Certain differences in the efficacy of both inhibitors on FLU reduction among strains were found. Metyrapone was shown to weakly decrease FLU-R formation only in the WR strain. No inhibitory effect of naloxone on FLU reduction was observed.
The in vitro formation of glucose conjugates of FLU and FLU-R was assayed in microsome-like fractions using LC-MS detection. FLU-R-gluc was the only glucose conjugate formed in vitro. The comparison of FLU-R-gluc in the 4 strains is shown in Fig. 4. The results were expressed as areas under peaks because the standard of FLU-R-gluc was not available.
Enzyme assays in vitro
The specific activities of several carbonyl-reducing enzymes toward model substrates were assayed in cytosol-like fractions from nematode homogenates of the 4 H. contortus strains. The specific activities of UGlcT towards the model substrate p-nitrophenol were tested and compared in microsome-like fractions. The results are summarized in Table 3. Very high activities of pyridinecarboxaldehyde reductases, low activities of naloxone reductases and metyrapone reductases, and no activity of menadione reductases were detected. The specific activities of pyridinecarboxaldehyde reductases were significantly lower in the resistant BR and WR strains as compared to the ISE strain. The activities of metyrapone reductases were significantly lower in the ISE-S strain than in the ISE strain. On the other hand, the activities of naloxone reductases were found in the WR and ISE-S strains, while no activity was detected in the ISE and BR strains.
ND, Not detected.
* Statistically significant difference from sensitive ISE strain.
The formation of glucose conjugates with p-nitrophenol was not observed in the susceptible ISE strain, but all other strains showed a significant ability to form p-nitrofenol glucosides in vitro.
DISCUSSION
A direct association between the increased activity of oxidation biotransformation enzymes and drug resistance has been described only in Fasciola hepatica (Robinson et al. Reference Robinson, Lawson, Trudgett, Hoey and Fairweather2004; Alvarez et al. Reference Alvarez, Solana, Mottier, Virkel, Fairweather and Lanusse2005). The aim of the present study was to find out whether the reduction and/or conjugation of anthelmintics differs between susceptible and resistant strains of H. contortus nematodes. The benzimidazole drug FLU was chosen, as its biotransformation consists of the reduction of a carbonyl group and the formation of glucose conjugates in H. contortus (Cvilink et al. Reference Cvilink, Skálová, Szotáková, Lamka, Kostiainen and Ketola2008b ). Four strains of H. contortus were used in the present study: the ISE strain (fully susceptible to anthelmintics), the ISE-S strain (resistant to ivermectin), the BR strain (resistant to benzimidazoles) and the WR strain (multi-resistant).
Firstly, the biotransformation of FLU was tested and compared ex vivo. FLU metabolites were identified and semi-quantified using LC-MS. In all tested strains, 4 FLU metabolites were detected: FLU with a reduced carbonyl group (FLU-R), a glucoside of FLU-R (FLU-R-gluc) and 2 glucosides of FLU (FLU-gluc1 and FLU-gluc2). All means of biotransformation of FLU signify its deactivation, as FLU-R is less anthelmintically active than FLU (Bártíková et al. Reference Bártíková, Křížová, Lamka, Kubíček, Skálová and Szotáková2010) and conjugation with glucose or glucuronic acid always decreases the biological activity of xenobiotics. When amounts of FLU metabolites were compared among the 4 strains, significant differences were found. A lower formation of all metabolites in the susceptible ISE strain than in the resistant strains was observed. The most active in FLU biotransformation were the nematodes of the multi-resistant WR strain that formed approximately 4–6 times more FLU metabolites than the nematodes of the ISE strain. These results showed that the resistant strains possessed a higher ability to deactivate toxic xenobiotics than the susceptible strain.
Consequently, the in vitro assays were performed to specify the data obtained ex vivo. Cytosol-like fractions from the nematode homogenate were incubated with FLU and NADPH. When in vitro FLU-R formation was compared among the H. contortus strains, almost no inter-strain differences were found. Also the activities of carbonyl-reducing enzymes toward model substrates differed only mildly among H. contortus strains. The discrepancy between the ex vivo and in vitro results might be due to different conditions of the in vitro and ex vivo assays. In in vitro assays, very high (saturated) concentrations of substrate and coenzyme NADPH are used and almost all regulatory systems (compartmentation, transporters, modulation of enzymes expression etc.) are lacking. As ex vivo experiments to a greater degree mimic natural conditions, we consider the results obtained in these experiments to be more relevant to an actual in vivo situation. On the other hand, in vitro experiments remain indispensable and useful for many purposes, e.g. for enzyme identification and characterization.
With the goal of characterizing the enzyme(s) responsible for FLU reduction, typical substrates of individual carbonyl-reducing enzymes were used in vitro as competitive inhibitors of FLU reduction. 4-Pyridinecarboxaldehyde is a good substrate especially for human aldehyde reductase (AKR1A); naloxone is preferentially reduced by aldo/keto reductases (AKR1C); menadione is a typical substrate of human carbonyl reductase (CBR); metyrapon is reduced by AKR1C and CBR (Ohara et al. Reference Ohara, Miyabe, Deyashiki, Matsuura and Hara1995; Maser and Opermann, Reference Maser and Oppermann1997; Palackal et al. Reference Palackal, Burczynski, Harvey and Penning2001; Gonzales-Covarrubias et al. Reference Gonzalez-Covarrubias, Kalabus and Blanco2008,). In H. contortus, FLU reduction was markedly inhibited by menadione and partly by 4-pyridinecarboxaldehyde. Using this result, the participation of CBR-like and AKR1A-like enzymes in FLU reduction in H. contortus could be estimated. Since the formation of FLU-R was also inhibited in the WR strain by metyrapone, this suggests the involvement of another enzyme (AKR1C-like enzyme) in FLU reduction in this strain. Certain inter-strain differences in the effect of inhibitors could be based on the different amount, affinity or activity of carbonyl-reducing enzymes in individual strains.
The second phase of FLU biotransformation in H. contortus consists of conjugation with glucose, which is catalysed by microsomal UGlcT. Therefore, the microsome-like fraction of nematodes and UDP-glucose was incubated with FLU or FLU-R, and the formed glucosides were analysed using LC-MS. In vitro only FLU-R-gluc was detected. Comparing the 4 strains, a significantly lower activity of UGlcT towards FLU-R was found in the microsomes of the susceptible ISE strain than in the resistant ones. When p-nitrophenol, a model substrate of UGlcT, was used no activity of UGlcT was detected in the ISE strain, while in the other strains this activity was evident. Taken together, the in vitro results confirmed the increased activity of UGlcT in the resistant H. contortus strains in comparison to the susceptible one. This finding, together with the higher formation of glucosides in resistant nematodes ex vivo, is the first indication that resistant strains of nematodes have an increased ability to deactivate anthelmintics via glucose conjugation.
CONCLUSIONS
In resistant strains of H. contortus, the ex vivo formation of all FLU metabolites was significantly higher than in the susceptible ISE strain. The in vitro data proved a significant increase in the activities of UGlcT in the resistant strains as opposed to the susceptible one. The increased activities of these detoxifying enzymes might protect the parasites against the toxic effect of the drugs, and thus contribute to drug resistance in these parasites.
ACKNOWLEDGEMENTS
The authors are grateful to Dr Frank Jackson of the Moredun Research Institute, Edinburgh, UK who provided the larvae of resistant and susceptible strains that were used in this work. We thank Daniel Paul Sampey, MFA, for correction of the English language. The technical assistance of Alena Pakostová is gratefully acknowledged. The project was supported by Czech Science Foundation (Grant P502/10/0217), and by the Charles University (Grant SVV 263 004).